Comparative efficacy, safety, and cardiovascular outcomes with once-weekly subcutaneous semaglutide in the treatment of type 2 diabetes: Insights from the SUSTAIN 1-7 trials
In clinical trials, significant weight loss was observed within several weeks to a few months of starting treatment
These effects include: Disclosed Side Effects: Inflammation of the pancreas (pancreatitis) Vision changes Kidney failure and other kidney problems Allergic reactions Additional Potential Dangers: Gallstones Acute gallbladder disease (cholecystitis) Thyroid tumors or thyroid cancer Diabetic retinopathy Hypoglycemia (low blood sugar) Gastroparesis (stomach paralysis) It is important for individuals to understand these potential risks and discuss them with a healthcare professional
A gradual, personalized dosing schedule is crucial for comfort, safety, and results
This makes injectable supplementation a reasonable approach for anyone with confirmed or suspected absorption problems, though it does not prove the combination provides benefits beyond separate administration
Seek medical help if you develop severe or persistent abdominal pain, repeated vomiting, signs of dehydration, fainting, confusion, yellowing of the skin or eyes, dark urine with abdominal pain, chest pain, shortness of breath, severe dizziness, severe weakness, or symptoms of alcohol withdrawal
